News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,367 Results
Type
Article (39556)
Company Profile (247)
Press Release (656564)
Section
Business (204104)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81010)
Employer Resources (172)
FDA (16156)
Job Trends (14843)
News (345050)
Policy (32501)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2547)
Accelerated approval (4)
Adcomms (20)
Allergies (80)
Alliances (49376)
ALS (83)
Alzheimer's disease (1357)
Antibody-drug conjugate (ADC) (109)
Approvals (16161)
Artificial intelligence (233)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (252)
Cancer (2015)
Cardiovascular disease (162)
Career advice (1673)
Career pathing (29)
CAR-T (140)
Cell therapy (397)
Cervical cancer (19)
Clinical research (65738)
Collaboration (769)
Compensation (466)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1985)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6338)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86223)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111707)
Executive appointments (649)
FDA (17279)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (691)
Gene editing (97)
Generative AI (18)
Gene therapy (278)
GLP-1 (685)
Government (4381)
Grass and pollen (4)
Guidances (49)
Healthcare (18808)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2713)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (311)
IPO (16486)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7901)
Liver cancer (70)
Lung cancer (293)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (268)
MASH (61)
Medical device (13326)
Medtech (13331)
Mergers & acquisitions (19407)
Metabolic disorders (632)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (1841)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2456)
Now hiring (37)
Obesity (340)
Opinion (201)
Ovarian cancer (72)
Pain (78)
Pancreatic cancer (76)
Parkinson's disease (138)
Partnered (20)
Patents (204)
Patient recruitment (97)
Peanut (46)
People (57101)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20471)
Phase II (28946)
Phase III (21579)
Pipeline (1057)
Podcasts (45)
Policy (113)
Postmarket research (2563)
Preclinical (8658)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5901)
Recruiting (65)
Regulatory (22155)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (121)
Series B (78)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2117)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (13)
Supply chain (60)
Tariffs (11)
The Weekly (27)
United States (21318)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (117)
Last 7 days (680)
Last 30 days (2687)
Last 365 days (33521)
2025 (8259)
2024 (35220)
2023 (40077)
2022 (51173)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37712)
Australia (6167)
California (5579)
Canada (1879)
China (476)
Colorado (247)
Connecticut (256)
Delaware (128)
Europe (80870)
Florida (828)
Georgia (196)
Idaho (57)
Illinois (500)
India (24)
Indiana (292)
Iowa (9)
Japan (143)
Kansas (101)
Kentucky (23)
Louisiana (8)
Maine (61)
Maryland (833)
Massachusetts (4195)
Michigan (209)
Minnesota (371)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1591)
New Mexico (28)
New York (1602)
North Carolina (922)
North Dakota (7)
Northern California (2456)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1261)
Puerto Rico (9)
Rhode Island (27)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2117)
Tennessee (95)
Texas (832)
Utah (164)
Virginia (130)
Washington D.C. (57)
Washington State (515)
West Virginia (3)
Wisconsin (49)
696,367 Results for "invivoscribe inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research
Invivoscribe and Complete Genomics announced that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics’ NGS platforms.
June 2, 2023
·
3 min read
Policy
Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay
We are pleased to announce that Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI and the EMA as a Class C CDx assay, meeting the stringent new IVDR 2017/746) requirements.
May 11, 2023
·
4 min read
Policy
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration to aid in the selection of patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia who may be eligible to receive treatment with Daiichi Sankyo’s VANFLYTA®.
July 21, 2023
·
3 min read
Business
Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine
Hitachi High-Tech Corporation (“Hitachi High-Tech”) has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. (“Invivoscribe”), a global provider of blood cancer testing kits and services, by undertaking a minority investment-based, third-party allotment of shares.
May 9, 2022
·
4 min read
Biotech Beach
Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in Japan
Invivoscribe is pleased to announce that their LeukoStrat CDx FLT3 Mutation Assay® has received updated reimbursement by Japan’s Ministry of Health, Labor and Welfare to aid in the selection of patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia who may be eligible to receive treatment with Daiichi Sankyo’s VANFLYTA®.
May 25, 2023
·
2 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
1 of 69,637
Next